Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Robert F. Schwabe et al. 2020 May;158(7):1913-28.
Cognitive deficit and white matter changes in persons with celiac disease: A population-based study. Iain D. Croall et al. 2020 Jun;158(8):2112-22.
Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s disease. William J. Sandborn et al. 2020 Jun;158(8):2123-38.e8.
The path to gastroenterology leadership: The preparation, the process, and achieving success. Joseph Ahn et al. 2020 Jun;158(8):2033-6.e4.
Clinical Gastroenterology and Hepatology
A user’s guide to de-escalating immunomodulator and biologic therapy in inflammatory bowel disease. Robert P. Hirten et al. 2020 May;18(6);1336-45.
Dietary guidance from the International Organization for the Study of Inflammatory Bowel Diseases. Arie Levine et al. 2020 May;18(6):1381-92.
Management of patients with immune checkpoint inhibitor-induced enterocolitis: A systematic review. Michael Collins et al. 2020 May;18(6):1393-403.e1.
Worldwide variations in demographics, management, and outcomes of acute pancreatitis. Bassem Matta et al. 2020 Jun;18(7):1567-75.e2.
Rapid recurrence of eosinophilic esophagitis activity after successful treatment in the observation phase of a randomized, double-blind, double-dummy trial. Evan S. Dellon et al. 2020 Jun;18(7):1483-92.e2.
Disparities in colorectal cancer screening in the United States before and after implementation of the Affordable Care Act. Folasade P. May et al. 2020 Jul;18(8):1796-804.e2.
Cost-effectiveness of telemedicine-directed specialized vs. standard care for patients with inflammatory bowel diseases in a randomized trial. Marin J. de Jong et al. 2020 Jul;18(8):1744-52.
Artificial intelligence-assisted system improves endoscopic identification of colorectal neoplasms. Shin-ei Kudo et al. 2020 Jul;18(8):1874-81.e2.